232 related articles for article (PubMed ID: 32899428)
1. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
[TBL] [Abstract][Full Text] [Related]
2. Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs.
Martinez-Paniagua MA; Vega MI; Huerta-Yepez S; Baritaki S; Vega GG; Hariharan K; Bonavida B
Mol Cancer Ther; 2012 Mar; 11(3):572-81. PubMed ID: 22267549
[TBL] [Abstract][Full Text] [Related]
3. Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (
Antonio-Andrés G; Rangel-Santiago J; Tirado-Rodríguez B; Martinez-Ruiz GU; Klunder-Klunder M; Vega MI; Lopez-Martinez B; Jiménez-Hernández E; Torres Nava J; Medina-Sanson A; Huerta-Yepez S
Leuk Lymphoma; 2018 Nov; 59(11):2628-2638. PubMed ID: 29616858
[TBL] [Abstract][Full Text] [Related]
4. A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells.
Vega MI; Baritaki S; Huerta-Yepez S; Martinez-Paniagua MA; Bonavida B
Leuk Lymphoma; 2011 Jan; 52(1):108-21. PubMed ID: 21133714
[TBL] [Abstract][Full Text] [Related]
5. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
6. Yin Yang 1 regulates the transcriptional repression of Survivin.
Galloway NR; Diaz Osterman CJ; Reiber K; Jutzy JM; Li F; Sui G; Soto U; Wall NR
Biochem Biophys Res Commun; 2014 Feb; 445(1):208-13. PubMed ID: 24508259
[TBL] [Abstract][Full Text] [Related]
7. Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression.
Castellano G; Torrisi E; Ligresti G; Nicoletti F; Malaponte G; Traval S; McCubrey JA; Canevari S; Libra M
Cell Cycle; 2010 Feb; 9(3):557-63. PubMed ID: 20081364
[TBL] [Abstract][Full Text] [Related]
8. Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis.
Zhang JJ; Zhu Y; Zhang XF; Liu DF; Wang Y; Yang C; Shi GD; Peng YP; Zhang K; Tian L; Miao Y; Jiang KR
Cancer Lett; 2017 Nov; 408():144-154. PubMed ID: 28867247
[TBL] [Abstract][Full Text] [Related]
9. YY1 Silencing Induces 5-Fluorouracil-Resistance and
Vivarelli S; Falzone L; Candido S; Bonavida B; Libra M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445183
[TBL] [Abstract][Full Text] [Related]
10. Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer.
Huerta-Yepez S; Baritaki S; Baay-Guzman G; Hernandez-Luna MA; Hernandez-Cueto A; Vega MI; Bonavida B
Nitric Oxide; 2013 Feb; 29():17-24. PubMed ID: 23246440
[TBL] [Abstract][Full Text] [Related]
11. Rituximab (chimeric anti-CD20) sensitizes B-NHL cell lines to Fas-induced apoptosis.
Vega MI; Huerta-Yepez S; Jazirehi AR; Garban H; Bonavida B
Oncogene; 2005 Dec; 24(55):8114-27. PubMed ID: 16103877
[TBL] [Abstract][Full Text] [Related]
12. Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis.
Galloway NR; Ball KF; Stiff T; Wall NR
Crit Rev Oncog; 2017; 22(1-2):23-36. PubMed ID: 29604934
[TBL] [Abstract][Full Text] [Related]
13. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression.
Bhattacharyya J; Mihara K; Ohtsubo M; Yasunaga S; Takei Y; Yanagihara K; Sakai A; Hoshi M; Takihara Y; Kimura A
Cancer Sci; 2012 Jan; 103(1):34-41. PubMed ID: 21999765
[TBL] [Abstract][Full Text] [Related]
15. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Overexpressed YY1 in Cancer Inhibits EMT and Metastasis.
Cho AA; Bonavida B
Crit Rev Oncog; 2017; 22(1-2):49-61. PubMed ID: 29604936
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1.
Baritaki S; Huerta-Yepez S; Sakai T; Spandidos DA; Bonavida B
Mol Cancer Ther; 2007 Apr; 6(4):1387-99. PubMed ID: 17431117
[TBL] [Abstract][Full Text] [Related]
18. The Yin and Yang of YY1 in tumor growth and suppression.
Khachigian LM
Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance.
Huerta-Yepez S; Liu H; Baritaki S; Del Lourdes Cebrera-Muñoz M; Rivera-Pazos C; Maldonado-Valenzuela A; Valencia-Hipolito A; Vega MI; Chen H; Berenson JR; Bonavida B
Int J Oncol; 2014 Sep; 45(3):1184-92. PubMed ID: 24970600
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1.
Huerta-Yepez S; Vega M; Escoto-Chavez SE; Murdock B; Sakai T; Baritaki S; Bonavida B
Nitric Oxide; 2009 Feb; 20(1):39-52. PubMed ID: 18778787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]